Prescription Device Cleared for Patients With Drug-Resistant Restless Legs Syndrome

The FDA has cleared the NTX100 Tonic Motor Activation System for the treatment of medication-refractory moderate to severe RLS.

Related Keywords

Ohio ,United States ,Asim Roy ,Drug Administration ,Ohio Sleep Medicine Institute ,Motor Activation ,Clinician App ,Clinical Global Impressions Improvement ,Principal Investigator ,Principal Investigators ,Medical Director ,Ohio Sleep Medicine ,